Literature DB >> 10777560

Three-dimensional clustering of human RAG2 gene mutations in severe combined immune deficiency.

B Corneo1, D Moshous, I Callebaut, R de Chasseval, A Fischer, J P de Villartay.   

Abstract

The V(D)J recombination, which leads to the somatic rearrangement of variable, diversity, and joining segments, is the mechanism accountable for the diversity of T cell receptor- and Ig-encoding genes. The products of the RAG1 and RAG2 genes are the lymphoid-specific factors responsible for the initiation of the V(D)J recombination through the generation of a DNA double strand break. RAG1 or RAG2 gene inactivation in the mouse leads to abortion of the V(D)J rearrangement process, early block in both T and B cell maturation, and, ultimately, to severe combined immune deficiency (SCID). A human SCID condition is also characterized by an absence of mature T and B lymphocytes and is associated with mutations in either RAG1- or RAG2-encoding genes. Based on the predicted beta-propeller three-dimensional structure model for RAG2, we found that six out of the seven mutations described to date in T-B-SCID patients are clustered on one side of the propeller, in regions exposed to solvent. This finding reinforces the biological significance of this predicted model and suggests that RAG1 interacts with RAG2 on one of the side of the scaffold formed by the beta-propeller.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777560     DOI: 10.1074/jbc.275.17.12672

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  The RAG proteins in V(D)J recombination: more than just a nuclease.

Authors:  M J Sadofsky
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

Review 2.  RAG1 and RAG2 in V(D)J recombination and transposition.

Authors:  S D Fugmann
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1.

Authors:  Alison M Motley; Pedro Brites; Lisya Gerez; Eveline Hogenhout; Janet Haasjes; Rob Benne; Henk F Tabak; Ronald J A Wanders; Hans R Waterham
Journal:  Am J Hum Genet       Date:  2002-01-07       Impact factor: 11.025

4.  Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.

Authors:  Norimoto Kobayashi; Kazunaga Agematsu; Kanji Sugita; Masahiro Sako; Shigeaki Nonoyama; Akihiro Yachie; Satoru Kumaki; Shigeru Tsuchiya; Hans D Ochs; Katsuo Sugita; Yoshimitsu Fukushima; Atsushi Komiyama
Journal:  Hum Genet       Date:  2003-02-19       Impact factor: 4.132

Review 5.  Role of recombination activating genes in the generation of antigen receptor diversity and beyond.

Authors:  Mayilaadumveettil Nishana; Sathees C Raghavan
Journal:  Immunology       Date:  2012-12       Impact factor: 7.397

6.  Metallo-beta-lactamase fold within nucleic acids processing enzymes: the beta-CASP family.

Authors:  Isabelle Callebaut; Despina Moshous; Jean-Paul Mornon; Jean-Pierre de Villartay
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

7.  Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.

Authors:  Ponpan Matangkasombut; Muriel Pichavant; Doris E Saez; Silvia Giliani; Evelina Mazzolari; Andrea Finocchi; Anna Villa; Cristina Sobacchi; Patricia Cortes; Dale T Umetsu; Luigi D Notarangelo
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

8.  Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.

Authors:  Irit Tirosh; Yasuhiro Yamazaki; Francesco Frugoni; Francesca A Ververs; Eric J Allenspach; Yu Zhang; Siobhan Burns; Waleed Al-Herz; Lenora Noroski; Jolan E Walter; Andrew R Gennery; Mirjam van der Burg; Luigi D Notarangelo; Yu Nee Lee
Journal:  J Allergy Clin Immunol       Date:  2018-06-18       Impact factor: 10.793

9.  Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.

Authors:  S S Meshaal; R E El Hawary; D S Abd Elaziz; A Eldash; R Alkady; S Lotfy; A A Mauracher; L Opitz; J Pachlopnik Schmid; M van der Burg; J Chou; N M Galal; J A Boutros; R Geha; A M Elmarsafy
Journal:  Clin Exp Immunol       Date:  2018-11-04       Impact factor: 4.330

10.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

Authors:  Jean-Pierre de Villartay; Annick Lim; Hamoud Al-Mousa; Sophie Dupont; Julie Déchanet-Merville; Edith Coumau-Gatbois; Marie-Lise Gougeon; Arnaud Lemainque; Céline Eidenschenk; Emmanuelle Jouanguy; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.